THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle
On Tuesday, the blockbuster anti-inflammatory medicine Stelara’s continued popularity helped Johnson & Johnson (JNJ.N) improve its 2023 profit prediction. The company also realized a...
Notice:
The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to
our Privacy Policy and our Cookie Policy.